Wealth Plan Partners, LLC Pa Vmed Inc. Transaction History

Wealth Plan Partners, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 01, 2023	BUY	$0.22 - $0.5 $1,100 - $2,500	5,000 Added 18.29%	32,335 $9.53 Million
Q2 2023 Jul 31, 2023	SELL	$0.35 - $0.56 $1,750 - $2,800	-5,000 Reduced 15.46%	27,335 $11.1 Million
Q4 2022 Feb 16, 2023	BUY	$0.41 - $18.6 $1,531 - $69,471	3,735 Added 13.06%	32,335 $13.3 Million
Q1 2022 May 03, 2022	BUY	$1.16 - $2.5 $1,426 - $3,075	1,230 Added 4.49%	28,600 $36,000
Q4 2021 Feb 01, 2022	BUY	$2.46 - $8.74 $418 - $1,485	170 Added 0.63%	27,370 $47,000
Q3 2021 Dec 09, 2021	SELL	$5.1 - $9.39 $79,050 - $145,545	-15,500 Reduced 36.3%	27,200 $232,000
Q1 2021 May 11, 2021	BUY	$2.01 - $5.55 $15,476 - $42,735	7,700 Added 22.0%	42,700 $190,000
Q1 2020 May 15, 2020	BUY	$1.15 - $3.29 $40,250 - $115,150	35,000 New	35,000 $79,000

2.24M

Ticker PAVM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 90,999,104
Market Cap $106M
Description
PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE); and EsoGuard, a bisulfite-converted ne...

Get notified when there are updates to the investment portfolio of Wealth Plan Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Wealth Plan Partners, LLC with notifications on news.